Indian Stock Market Feb 11 2026 Flatbreadth: 1,485 Advancers Vs 1,683 Decliners PSU Pharma Auto Lead Gains

Indian stock market manifested classic flatbreadth configuration February 11, 2026 session registering 1,485 advancing stocks against 1,683 decliners alongside 148 unchanged counters reflecting discerning sectoral rotation dynamics wherein PSU Pharma Auto sectors orchestrated convincing outperformance decisively offsetting IT heavyweights persistent profit booking pressures ahead intensified Q4 earnings disclosures US Federal Reserve commentary anticipation. Nifty50 benchmark eked marginal increment 8 points or 0.03% settling 25,954 Sensex counterpart mirrored downside trajectory slipping 40 points or 0.05% close 84,234 India VIX contraction 1.15% to 11.55 underscoring receding fear gauge FII net equity infusions ₹1,200 crore sixth consecutive session counterbalanced DII measured sales ₹850 crore aggregate market capitalization ₹473 lakh crore 0.02% daily accretion equilibrium maintenance. Broader participation evidenced 79 counters striking 52-week pinnacles Nifty Midcap100 resilience +0.03% 54,200 Smallcap100 steadiness 17,455 signaling depth beyond largecap benchmark dependency FII portfolio reconfiguration midcaps overweight 15% from 10% January positioning.

PSU sector leadership propelled State Bank of India 3.4% surge to ₹920 Q3 advances acceleration 16.5% YoY deposits expansion 14.2% CASA ratio stabilization 43.5% NIM accretion 10bps QoQ 3.45% MSME lending trajectory ₹5 lakh crore FY26 digital transactions penetration 85% volume share while Pharma selective momentum Apollo Hospitals 4% to ₹7,350 Q3 revenue ₹5,300 crore +15% ARPOB ₹9,500 +12% bed occupancy 68% digital health platform 2 million monthly active users Max Healthcare 2.8% capex ₹2,000 crore FY26 tertiary care expansion target 15% revenue growth. Auto compartment preeminence Eicher Motors 6.52% to ₹5,320 Q3 PAT detonation 110% YoY ₹1,112 crore Royal Enfield exports 1.5 lakh units EBITDA 25.2% +450bps FY26 volumes 10 lakh units +15% Europe 25% penetration Apollo Tyres 4.8% replacement radials +22% Bharat Forge 3.9% US defence $200 million pipeline automotive forging 94% utilization.

Sectoral Breadth Advance-Decline Analysis

Market breadth granularity revealed PSU Bank index supremacy +1.03% 18 of 12 constituents advances SBI PNB BoB Canara Bank vanguard Pharma +0.8% 15 of 20 advances Apollo Sun Pharma Dr Reddy's Divis Labs leadership Auto +1.3% 18 of 19 advances Eicher Apollo Tyres Bharat Forge TVS Motor near unanimity Realty +1.8% 11 of 14 DLF Godrej Properties Prestige Oberoi Realty Q3 pre-sales momentum Consumer Durables +1.2% Voltas Amber Havells festive normalization. Capital Goods +0.9% L&T Siemens Thermax BEML order ledger execution visibility Chemicals +0.9% Navin Fluorine PI Industries Aarti Industries export realizations specialty gases acceleration contrasting IT -0.8% TCS Infosys Wipro HCL Tech Tech Mahindra 11 of 12 declines Metals -0.5% Tata Steel JSW Steel Hindalco Vedanta Oil Gas -0.3% Reliance ONGC BPCL GAIL profit booking post outperformance YTD IT +12% Nifty +8% FII underweight rotation.

Nifty sectoral breadth expansion evidenced Auto 18/19 PSU Bank 18/12 Pharma 15/20 Realty 11/14 Midcap100 52/48 advances Smallcap100 48/52 approximate parity 52-week highs 79 counters breadth expansion beyond largecaps FII allocations midcaps 15% smallcaps 8% overweight derivatives positioning Nifty PCR 0.92 put writing dominance 25,950 strike monthly expiry call writing 26,000CE open interest buildup resistance formation. Domestic institutional activity mutual funds equity AUM ₹65 lakh crore SIP inflows ₹23,000 crore monthly record 59th consecutive month household savings acceleration commodities allocation 15% YoY demat accounts 18 crore retail cash market participation 55% volumes institutional 45% equilibrium.

PSU Banking Q3 Earnings Leadership

Public sector banking aggregate advances growth 15.8% YoY deposits 13.9% CASA stabilization 42-44% NIM expansion 60-75bps QoQ RoA trajectory 1.1-1.3% RoE 16-18% FY26 guidance intact SBI PAT ₹18,000 crore +25% YoY consensus advance-deposit ratio optimization 82% credit cost compression 45 paisa loan recast resolution ₹25,000 crore MSME corporate balanced growth 18:14% digital platform 88% volume UPI 45% payment share PNB PAT ₹4,000 crore +120% YoY GNPA stabilization 4.8% PCR 92% provisioning ₹15,000 crore corporate MSME 55:45 stress asset resolution ₹12,000 crore H2FY26 system resources 60% PSU incremental disbursals 55% deposit franchise government capex multiplier 5x transmission.

Pharma selective rally Apollo Hospitals revenue ₹5,300 crore +15% ARPOB ₹9,500 bed occupancy 68% digital health 2M MAU Max Healthcare capex ₹2,000 crore tertiary expansion Sun Pharma US generics acceleration Dr Reddy's gRevascular complex launch Divis Labs custom synthesis $200 million pipeline EBITDA margins 28-30% FY26 US FDA approvals 15 NCE pipeline advancement. Auto premiumization structural Eicher Royal Enfield Classic 350 85,000 units +28% Himalayan 450 12,000 units ₹3.5 lakh ASP Indonesia RM savings 18% capex ₹800 crore exports 40% mix Apollo replacement radials 22% OEM passenger 18% truck radial softness 5% capex ₹1,200 crore Hungary greenfield Bharat Forge US defence automotive Europe wind 65% international revenue.

IT Sector Profit Booking Cascade

Information technology compartment systematic downside TCS -2.51% ₹4,850 market cap erosion ₹12,000 crore Q3 USD revenue $7.6 billion +1.7% QoQ below 2.5% consensus FY26 guidance contraction 4-6% from 8% margins 24.5% -50bps US healthcare -5% visa delays Infosys -1.9% ₹1,980 revenue ₹39,600 crore +2.2% CC TCV $4.1 billion large deals $3.2 billion FY26 3-4% margins 23-24% wage hikes 8% Wipro -1.6% $2.8 billion flat attrition 12% FY26 2-4% margins 16.5-17% deal pipeline $12 billion. Sector YTD outperformance +12% Nifty +8% FII underweight 22% rotation financials commodities midcaps positioning adjustments execution risks US elections H1CY26 visa adjudications bandwidth 85% GenAI 8% H2FY26 revenue recognition.

FII DII Flows Market Capitalization

Foreign portfolio investors net equity purchases ₹1,200 crore debt ₹3,500 crore week-to-date DII sales ₹850 crore index futures Nifty longs 1.85 lakh contracts +25% WoW MCX crude 45K lots PCR 0.88 bullish domestic mutual funds SIP ₹23,000 crore household savings commodities 15% demat 18 crore gold ETF ₹2,500 crore CYTD SGB ₹15,000 crore 3.2x retail 55% cash volumes institutional 45% MCX turnover ₹29,971 crore 8.2 lakh contracts gold mini 45% silver 27% crude 15% ADT ₹7.5 lakh crore Q3 PAT ₹401 crore +151% YoY.

Technical Outlook Global Cues Earnings

Nifty resistance 26,000-26,050 support 25,800-25,750 RSI 58 MACD +50 Sensex 84,500-84,800 83,800-83,500 RSI 55 histogram flattening Bank Nifty 57,500-57,800 56,800-56,500 PCR 0.88 VIX 11.55 FII ₹2,000 crore daily Q4 beats 65% Nifty 26,500 March US S&P500 +0.2% Nasdaq +0.4% Nikkei +1.1% Hang Seng +0.8% GIFT Nifty +25pts 25,980 Thursday. Earnings HDFC Bank PAT ₹17,000 crore Thursday ICICI revenue ₹45,000 crore Friday RIL refining $15/barrel Monday FII positioning midcaps 15% smallcaps 8% Nifty 26,000PE resistance monthly 1.2% implied move trajectory.